Structural Heart Imaging Market

The market for Structural Heart Imaging was estimated at $9.5 billion in 2024; it is anticipated to increase to $13.7 billion by 2030, with projections indicating growth to around $18.7 billion by 2035.

Report ID:DS1801111

Author:Debadatta Patel - Senior Consultant

Published Date:January 2025

Datatree

Life Science

Medical Device

Structural Heart Imaging

Customization Available

Structural Heart Imaging - 2024-2034

Market Outlook
Market Key Insights
Growth Opportunity
Market Dynamics
Application
Recent Development
Impact Analysis

Report Summary

Market Data

Methodology

Table of Contents

Report Summary

Market Data

Methodology

Table of Contents

Global Structural Heart Imaging Market Outlook

Revenue, 2024

$9.5B

Forecast, 2034

$17.6B

CAGR, 2025 - 2034

6.4%

The Structural Heart Imaging industry revenue is expected to be around $10.1 billion in 2025 and expected to showcase growth with 6.4% CAGR between 2025 and 2034. The contemporary structural heart imaging industry is developing in tandem with significant advances in the fields of interventional cardiology and cardiac imaging. It is crucial for deciding on treatments for the most serious of structural and valvular heart disease conditions. Currently cardiology has a growing importance due to the increasing prevalence of heart conditions. This significance is also due to the new minimally invasive treatments and interventions which involve inserting catheters. Indeed, a further boost to the demand comes from the crucial role that real time and intra procedure imaging guidance has in improving patient care outcomes, in cutting procedure time and in cutting the incidence of any procedure related complications. The development of echocardiography, cardiac MRI and CT scans have led to an increased importance of cardiac imaging in the treatment of heart conditions. It is used as a key element of heart disease diagnosis and treatment.

A variety of non invasive imaging technologies are used to help the diagnosis of conditions of the hearts structure that require catheter based interventions. These technologies include cardiac computed tomography, cardiac magnetic resonance imaging and transthoracic echocardiography. The system incorporates the following key technologies: Three and four dimensional imaging techniques, quantifiable measures of blood flow and cardiovascular health, and full integration with the imaging equipment used by interventional cardiologists for diagnostic purposes and helping during procedures. The former application and the latter account for 62.5% of system use. Structural Heart Imaging saw the Angiogram modality generate 3.28 billion U. S dollars in sales in 2024, demonstrating its key role in a variety of treatments and interventions, including planning valvular therapies and complex catheter procedures. The increasing demand for cardiac imaging is driven by the enhanced capabilities of AI and by workflows which have been optimised through the use of CT and MRI scans. This is also furthered by the increasing use of fusion imaging for heart procedures. This results in the increasing adoption of heart imaging.

Structural Heart Imaging market outlook with forecast trends, drivers, opportunities, supply chain, and competition 2024-2034 — Structural Heart Imaging Market Outlook

Market Key Insights

The SHI market is expected to expand from 9.5 billion dollars in the year 2024 to 17.6 billion dollars by 2034. The sector is witnessing a compound annual growth rate of 6.4 %; a development which can be attributed to the rising need across various domains including cardiac diseases diagnosis, treatment planning and monitoring and research and training.
Leading competitors in the medical imaging equipment market include GE Healthcare, Siemens Healthineers and Philips.
The US and German markets are forecast to lead the way in the structural heart imaging market, each enjoying growth rates between 4.2% and 6.1% by 2030.
Growth in emerging markets such as India, South Africa and Brazil are expected to be the greatest, with 7.4% to 8.8% Compound Annual Growth Rate.
Technological advancements in imaging technologies have a greater impact on the markets value chain in the United States and Germany. By 2030, this is expected to add $429 million to the Structural Heart Imagingindustry'srevenue.
The SHI market is expected to expand by $8.1 billion over the period 2024 to 2034. In this period it is expected that a greater proportion of the market will be made up of pre procedure planning and intra procedure guidance application from manufacturers.
The incidence of cardiovascular diseases is escalating, and in parallel, the latest imaging technology has led to rapid growth in the field of structural heart imaging. It is predicted that by 2034 the structural heart imaging market will have increased by 86% since 2024.

Structural Heart Imaging - Country Share Analysis

Opportunities in the Structural Heart Imaging

There is also an increasing trend of private cardiac clinics and private radiology centres purchasing the Structural Heart Imaging MRI on a capital basis. These buyers are targeting the younger population with inherited cardiomyopathies. These centres require high resolution, radiation free cardiac MRI, particularly for sports cardiology screening and patients in whom echocardiography gives a poor image. By 2030, structural heart imaging with MRI is predicted to reach 1.36 billion dollars in comparison to 2024s 0.87 billion dollars. Cardiac MRI units are expected to be taken up most quickly in towns where cardiac care is funded by the private sector.

Growth Opportunities in North America and Asia-Pacific

The demand for structural heart imaging in North America is driven by the intra procedure guidance required for catheter based structural heart interventions. Techniques such as echocardiography, cardiac MRI and 3D imaging are used in conjunction with cardiac CT. Key region's of development are in imaging platforms which are equipped with AI and have streamlined workflows. These platforms can reduce procedure time, enable more complex imaging for procedures such as TAVR and mitral valve repair and can support the expansion of structural heart programs. Competitive strategies in this industry involve portfolios with multiple modalities and services tailored to differentiate the vendor. Key aspects for buyers in the medical imaging market include system interoperability and training options. In the region, there are a number of factors driving the market. These include a high prevalence of heart disease caused by faulty heart valves, a rapid increase in cardiac treatment procedures in community hospitals, financial incentives that favour the use of in operating theatre imaging, and reimbursement systems that are supportive of high quality heart diagnostic tests.

Across the Asia Pacific region, an expansion of Structural Heart Imaging is primarily due to diagnostic evaluations being carried out by the healthcare systems. The healthcare systems in this region are utilising echocardiography and cardiac imaging to tackle a number of heart conditions that have been underdiagnosed. Potential advantages may be found in the establishment of adaptable systems that integrate initial diagnostic testing with the planning phase prior to surgery. These include systems at a middle level of complexity that can be upgraded to include three dimensional images during surgery and images taken in the course of the operation. Additionally, there should be a system to supply information via the internet so that various hospitals in a particular region can refer patients to one another. Those who are successful in the industry have taken their products and services to the local level by adapting their features and pricing, and have developed relationships with leading heart treatment facilities. They also offer customised financing and maintenance options to allow them to gain a foothold in these hospitals. The main reasons for this growth are a rise in the number of people who suffer from heart disease, investment by the government in the facilities used for heart care, an increase in the procedures that require this form of imaging and a greater emphasis on early diagnosis and standardising the process of taking images of the heart.

Market Dynamics and Supply Chain

Driver: Increasing Prevalence of Cardiovascular Diseases, and Rising Healthcare Expenditures

The significant rise, in the prevalence of heart conditions acts as a key factor driving the growth of the Structural Heart Imaging market. At heart diseases are also a major global public health issue that demands immediate attention; therefore structural heart imaging has also gained importance for diagnosis and therapy purposes eventually fostering market expansion. The increase in healthcare spending globally has also also contributed to the growth of the structural heart imaging market. As more resources are also directed towards innovation and research in the healthcare industry the rising demand, for advanced and effective heart imaging systems is also highlighted.

The field of structural heart imaging technology has also witnessed significant advancements with the introduction of more precise and effective systems, at a fast rate. This progress has also enhanced comfort levels reached broader range of detectable conditions and elevated diagnostic accuracy overall resulting in the markets continual growth.

Restraint: High Cost of Procedures

Certainly the expensive nature of structural heart imaging processes poses a challenge for many healthcare providers and patients alike due to the high costs associated with cutting edge imaging tools such as CT scans and MRIs among others like echocardiography machines. With their steep price tags putting a strain on budgets of smaller healthcare providers it becomes difficult for them to offer these advanced services. The financial burden often falls on patients, with incomes making it challenging for them to access such advanced imaging technologies. This financial barrier ultimately hinders the adoption of structural heart imaging procedures dampening market growth prospects significantly.

Opportunity: Growing demand for Structural Heart Imaging in transcatheter valve replacement among aging heart failure patients globally and Adoption of AI-enhanced CT Structural Heart Imaging for preprocedural planning in high-volume interventional cardiology centers

The growing need for structural heart imaging is being driven by the increasing standardisation of transcatheter techniques for the replacement of valves in the heart in elderly patients suffering from serious valve problems. The use of TAVR, TMVR and left atrial appendage closure procedures is being complemented by more cardiac imaging services in a hospital. These include echocardiograms and angiograms. The echocardiogram medical imaging technique holds the greatest share of the market worldwide. The share is expected to increase from $2.95 billion in 2024 to $4.02 billion by 2030. The diagnostic angiogram procedure, is second in terms of global market size. Its share is projected to rise from $3.28 billion in 2024 to $4.74 billion by 2030. In the forecast period it is predicted that angiogram based intraoperative imaging will be used most frequently in high volume interventional cardiology centres.

Advanced cardiac CT technologies are today revolutionising the process of planning structural heart interventions, by providing detailed imaging of the heart. The integration of three dimensional imaging alongside automated size measuring tools and AI assisted diagnostics has led to faster surgeries and fewer complications by simplifying device selection. The computed tomography modality, which is now valued at 1.87 billion dollars in 2024, is expected to increase to 3.02 billion by the year 2030. In terms of annual growth rate, CT has the highest% age with 8.3%.Applications where the planning of the procedure requires detailed images of cardiac structures are expected to experience the strongest growth rate. More information about heart CT scans can be found by clicking the link above.

Challenge: Regulatory Compliance Challenges

The market for structural heart imaging is also encountering difficulties in meeting standards as regulations for medical devices are continually changing and demanding meticulous adherence, from manufacturers who must invest substantial resources to ensure compliance.

Supply Chain Landscape

Cardiac Imaging Components

GE HealthcareCanon Medical SystemsKoninklijke Philips N.V

Structural Heart Imaging

Siemens HealthineersGE HealthcareCanon Medical Systems

Imaging Distribution

Siemens HealthineersKoninklijke Philips N.V.Shanghai United Imaging Healthcare

Clinical End Users

HospitalsCardiology ClinicsDiagnostic Imaging Centers

Cardiac Imaging Components

GE HealthcareCanon Medical SystemsKoninklijke Philips N.V

Structural Heart Imaging

Siemens HealthineersGE HealthcareCanon Medical Systems

Imaging Distribution

Siemens HealthineersKoninklijke Philips N.V.Shanghai United Imaging Healthcare

Clinical End Users

HospitalsCardiology ClinicsDiagnostic Imaging Centers

Structural Heart Imaging - Supply Chain

Use Cases of Structural Heart Imaging in Cardiac Diseases Diagnosis & Research

Cardiac Diseases Diagnosis : Structural heart imaging is crucial for identifying heart conditions like congenital defects and heart diseases that affect the structure of the heart muscles itself and cardiomopathy diseases of the heart muscle walls and betters patient results by providing detailed3D images for precise diagnosis Siemens Healthineers and Philips are at the forefront, with their cutting edge structural heart imaging technologies enhancing cardiac disease detection through detailed and accurate imaging solutions.

Treatment Planning and Monitoring : Structural heart imaging plays a role in preparing and overseeing treatments for heart conditions such as cardiac diseases by providing detailed measurements of the heart structures and real time visualizations during surgeries to monitor progress accurately and track treatment effectiveness over time. Key industry players, like GE Healthcare and Canon Medical Systems lead the market with state of the art structural heart imaging equipment that assists in creating surgical plans and monitoring the success of treatments regularly.

Research and Training : Structural heart imaging is commonly applied in research and training as well. Sophisticated imaging techniques offer detailed visuals of the hearts structures. This contributes to the progress of medical research by providing high quality images that also double up as effective training aids, for healthcare practitioners.

Recent Developments

Advancements driven by technology have spurred developments 3d and 4d echocardiography tools for diagnosing heart defects due, to the rising occurrence of cardiovascular diseases worldwide.

December 2024 : GE Healthcare introduced a product called Streamline SHPI Pro that uses advanced AI technology to improve the efficiency and accuracy of processing structural heart images.

October 2024 : Edwards Lifesciences Corporation has received the light from the FDA for its groundbreaking 4 D Transesophageal Echocardiogram technology, which is designed for non invasive imaging of the hearts structure.

August 2024 : Philips Healthcare unveiled its state of the art Spectral HeartCT technology as part of its expansion, into the field of structural heart imaging.

Impact of Industry Transitions on the Structural Heart Imaging Market

As a core segment of the Medical Device industry, the Structural Heart Imaging market develops in line with broader industry shifts. Over recent years, transitions such as Advancements in Imaging Technologies and Adoption of AI & ML in Healthcare have redefined priorities across the Medical Device sector, influencing how the Structural Heart Imaging market evolves in terms of demand, applications and competitive dynamics. These transitions highlight the structural changes shaping long-term growth opportunities.

Advancements in Imaging Technologies

Significant technological progress is presently the driving force behind the expansion of the structural heart imaging market, notably within both the US and Germany, where rapid developments in cardiac CT, cardiac MRI and 3D ultrasound have restructured the industry, affecting firms which manufacture devices to hospital cath labs. Recent developments in cardiac imaging have led to the creation of high resolution images, the process of treatments is thus simplified by enabling doctors to plan in advance, whilst performing the procedure and following up after. This results in more complex treatments and the demand for better quality equipment. By 2030, structural heart imaging is forecast to provide a further 429 million dollars in revenue due to healthcare providers adopting image guided interventions and cardiovascular imaging suites. This is set to make advanced imaging capabilities a main selling point for the suppliers and leading heart disorder clinics.

Adoption of AI & ML in Healthcare

The healthcare sector is witnessing a revolutionary shift through the fusion of AI and ML technologies. This phenomenon is significantly impacting the structural heart imaging field.